Labeler · US market

Lohxa

Lohxa is a US drug labeler with US FDA registrations covering 2 drug concepts (2 currently active) across 2 packages.

ACTIVE — US

openFDA · updated weekly

Labeler codes70166

Active drugs2

Registrations2 active / 2

Packages2

Sole supplier of0 drugs

Portfolio2 drugs · US

Every drug concept this labeler has US registrations for, by package count.

Drug	Type	NDCs	Packages	Status
Mupirocin ointment	rx	1	2	SUPPLYING
Atovaquone suspension	rx	1	0	SUPPLYING

At a glance

TypeLabeler
Labeler codes70166
Filing names1
Drugs (active)2
Drugs (all time)2
US registrations2
Packages2

Recent events

Shortages, recalls, and registration changes across all filing names.

Dec 21, 2021
RECALLRecall (Class I): SENNA Syrup (sennosides) 8.8 mg/ 5 mL unit-dose cups, packaged in 24 cups per carton, Mfg for: AvKARE, TN 38478, NDC 5…
Oct 28, 2020
RECALLRecall (Class I): Chlorhexidine Gluconate Oral Rinse USP, 0.12%, Alcohol Free, packaged in 15 mL unit does cups (barcode 7016602715), pac…
Mar 25, 2019
RECALLRecall (Class II): Phenobarbital Oral Solution, USP 20 mg/5mL, unit dose cup, Rx Only, Rpkg. By.Lohxa Worcester, MA 01608 NDC 70166-536-…
Mar 25, 2019
RECALLRecall (Class II): Bismuth Subsalicylate Oral Suspension 262mg/15mL, unit dose cups, OTC, Rpkg. By.: Lohxa Worcester, MA, NDC 70166-059-01

Watch this company

Alerts for recalls, exits, and new registrations.

Facility locations, FDA inspections, and parent-company mapping are on the roadmap. Name variants reported to FDA under different spellings are merged into this profile; figures cover the entity across all its filing names.